Top in cardiology: Combination cholesterol therapy, sudden cardiac death

The FDA recently approved a therapy that combines rosuvastatin, a statin for LDL reduction, and ezetimibe, a cholesterol absorption inhibitor, for adults with primary nonfamilial hyperlipidemia or homozygous familial hypercholesterolemia.

The announcement was the top story in cardiology last week.

Another top story was about a study that revealed infants born small for gestational age had a greater risk for cardiac death at a young age. Compared with a reference group, these patients had a higher relative risk for cardiac death at 5 years, 10 years and 30 years.

Read these and more top stories in cardiology below:

Rosuvastatin/ezetimibe tablet approved for LDL reduction in hyperlipidemia, HoFH

Althera announced the FDA approved its Roszet (rosuvastatin/ezetimibe) tablets as an adjunct to diet for treatment of elevated LDL in adults with primary nonfamilial hyperlipidemia or homozygous familial hypercholesterolemia. Read more.

Low birth weight associated with sudden cardiac death at young age

Children born small for gestational age experienced greater relative risk for sudden cardiac death at a young age compared with those born a normal weight, according to data published in the Journal of the American Heart Association. Read more.

Low-intensity exercise may fail to preserve heart health in long-term space travelers

Sustained, low-intensity exercise may not be enough to preserve left ventricular mass and diastolic diameter in long-term space travelers, according to a research letter published in Circulation. Read more.

Higher CV health scores tied to lower risk for major CVD events

If all U.S. adults attained high cardiovascular health status, 2 million adult CVD events could be prevented annually, according to a study published in the Journal of the American Heart Association. Read more.

Longer working hours increase risk for second CV event after MI

Patients who returned to work after a myocardial infarction and worked more than 55 hours per week had elevated risk for having a second cardiovascular event, according to a study published in the Journal of the American College of Cardiology. Read more.